撒哈拉沙漠的尘埃诱导了与肺部疾病相关的细胞因子,花细胞-巨细胞殖民地刺激因子和花细胞殖民地刺激因子
Gerrit Bredeck1, Jochen Dobner1, Andrea Rossi1
1IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany.
Environment international
|March 20, 2024
概括
暴露于撒哈拉沙漠尘埃会通过增加肺细胞中的颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 和颗粒细胞殖民地刺激因子 (G-CSF) 来触发不良呼吸道影响,这可能表明新的治疗点.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 分子生物学分子生物学
背景情况:
- 沙漠尘埃是一种复杂的污染物混合物,与呼吸系统问题有关.
- 沙漠尘埃引发的特定生物通路在很大程度上仍未确定.
- 了解这些途径对于减轻健康影响至关重要.
研究的目的:
- 调查撒哈拉沙漠尘埃 (SD) 呼吸系统影响背后的分子机制.
- 为了确定特定的基因和细胞因子通过SD暴露升级调节.
- 探索尘埃引起的肺部疾病的潜在治疗点.
主要方法:
- 人体在体外共培养的膜上皮细胞 (A549) 和巨细胞 (THP-1) 被暴露在撒哈拉沙漠尘埃和DQ12石英尘埃中.
- 用RNA测序来分析基因表达变化.
- 定量逆转录酶PCR (qRT-PCR) 和细胞因子分泌量测试证实了这些关键发现.
主要成果:
- 撒哈拉沙漠的尘埃显著提高了颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 和颗粒细胞殖民地刺激因子 (G-CSF) 的基因表达.
- 这些增加是剂量依赖的,在最高度下观察到显著的折叠变化.
- SD暴露也增强了GM-CSF和G-CSF蛋白质的分泌.
结论:
- 已确定GM-CSF和G-CSF是撒哈拉沙漠尘埃对呼吸系统有害影响的关键分子信使.
- 这些细胞因子与喘和纤维化等肺部疾病有关.
- 向GM-CSF和G-CSF可能为非人为空气污染物引起的肺部疾病提供治疗策略.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:17Other Pulmonary Disorders
838
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
838
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K